KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutanix (NTNX) Asset Writedowns and Impairment: 2020-2023

Historic Asset Writedowns and Impairment for Nutanix (NTNX) over the last 1 years, with Jul 2023 value amounting to $69,000.

  • Nutanix's Asset Writedowns and Impairment fell 88.44% to $69,000 in Q3 2023 from the same period last year, while for Jul 2023 it was -$443,000, marking a year-over-year decrease of 109.24%. This contributed to the annual value of -$1.0 million for FY2023, which is 274.20% down from last year.
  • Per Nutanix's latest filing, its Asset Writedowns and Impairment stood at $69,000 for Q3 2023, which was up 108.57% from -$805,000 recorded in Q1 2023.
  • Over the past 5 years, Nutanix's Asset Writedowns and Impairment peaked at $3.0 million during Q1 2020, and registered a low of -$1.4 million during Q3 2021.
  • Moreover, its 3-year median value for Asset Writedowns and Impairment was $69,000 (2023), whereas its average is $536,429.
  • In the last 5 years, Nutanix's Asset Writedowns and Impairment soared by 142.58% in 2022 and then slumped by 88.44% in 2023.
  • Quarterly analysis of 4 years shows Nutanix's Asset Writedowns and Impairment stood at $2.8 million in 2020, then decreased by 6.67% to -$1.4 million in 2021, then surged by 142.58% to -$304,000 in 2022, then tumbled by 88.44% to $69,000 in 2023.
  • Its last three reported values are $69,000 in Q3 2023, -$805,000 for Q1 2023, and -$304,000 during Q4 2022.